SCHEMBL30259364

SCHEMBL30259364

O=C(O)c1ccc2c(c1)NCN2C[C@@H]1CCO1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4C Q9H3R0 1/20 0.42
▸ ALDH1A1 P00352 4/20 0.40
▸ TSHR P16473 2/20 0.38
▸ PTGER4 P35408 2/20 0.37
▸ HTT P42858 1/20 0.36
▸ HCAR3 P49019 2/20 0.35
▸ ALOX5 P09917 1/20 0.35
▸ HSD17B10 Q99714 3/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ GAA P10253 2/20 0.34
▸ POLB P06746 1/20 0.34
▸ NR4A1 P22736 1/20 0.34
▸ MYC P01106 1/20 0.34
▸ ESR1 P03372 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ PTPN7 P35236 1/20 0.34
▸ MAPK1 P28482 2/20 0.33
▸ LMNA P02545 1/20 0.33
▸ GLA P06280 1/20 0.33
▸ HDAC1 Q13547 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30431544 0.74 KDM4C (0.34) KDM4CALDH1A1PTGER4HTTHSD17B10
SCHEMBL18630781 0.69 HDAC1 (0.51) ALDH1A1HTTHCAR3ALOX5HSD17B10
SCHEMBL29149803 0.68 ALDH1A1 (0.37) KDM4CALDH1A1TSHRPTGER4HTT
SCHEMBL22402499 0.68 ALDH1A1 (0.39) KDM4CALDH1A1TSHRPTGER4HTT
SCHEMBL22402504 0.68 ALDH1A1 (0.39) KDM4CALDH1A1TSHRPTGER4HTT
SCHEMBL23517085 0.67 ALDH1A1 (0.42) KDM4CALDH1A1TSHRPTGER4HTT
SCHEMBL30455071 0.67 MCL1 (0.46) KDM4CALDH1A1TSHRPTGER4HTT
SCHEMBL31066561 0.67 ALDH1A1 (0.42) KDM4CALDH1A1TSHRPTGER4HTT
SCHEMBL17263136 0.66 KDM4E (0.41) KDM4CALDH1A1TSHRHCAR3HSD17B10
SCHEMBL31140527 0.66 PTGER4 (0.58) KDM4CPTGER4HCAR3HSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240360109-A1 CYCLOALKENE DERIVATIVE REGULATOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) 2024-10-31 — — US disclosed
EP-4382525-A1 CYCLOALKENE DERIVATIVE REGULATOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Shanghai Hansoh Biomedical Co., Ltd. (CN) 2024-06-12 — — EP disclosed
WO-2023011539-A1 CYCLOALKENE DERIVATIVE REGULATOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF 上海翰森生物医药科技有限公司 2023-02-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240360109-A1 CYCLOALKENE DERIVATIVE REGULATOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF CYP51A1, FAR1, CYP46A1 KDM4C 4617/4885ALDH1A1 1750/4885TSHR 2255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback